Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)
Yale University · with United States Department of Defense · NCT04936009
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–40 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 60
- US sites recruiting
- 1
- Study start
- March 17, 2022
- Record last updated
- February 9, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a randomized interventional study designed to evaluate the effects of repetitive Transcranial Magnetic Stimulation (rTMS) on neural and behavioral facets of social cognition in adults with autism spectrum disorder (ASD).
Being studied: Transcranial Magnetic Stimulation (TMS)
Conditions: Autism Spectrum Disorder
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Individuals between the ages of 18 and 40 years old with typical development or with a diagnosis of autism spectrum disorder.
- Individuals able to participate in an EEG and eye-tracking experiment.
Exclusion Criteria
- Participants reporting significant head trauma or serious brain illness.
- Participants with major psychiatric illness that would preclude completion of study measures.
- Participants with a history of serious medical illness, stroke, seizures, epileptiform EEG abnormalities, or family history of seizures.
- Participants taking prescription medications that may affect cognitive processes under study.
- Participants who have taken alcohol or recreational drugs within the preceding 24 hours.
- Females of known/suspected pregnancy or who test positive on a pregnancy test.
- Participants with a history of metalworking or injury by shrapnel or metallic objects are also excluded.
- Participants with a history of prior TMS therapy or use of an investigational drug within 12 weeks of visit.
- Participants with an IQ (intelligence quotient) below 80.
Recruiting US locations
Yale University Child Study Center
New Haven, CT 06520
Site contact: Nicole Wright · 860-785-3488 · n.wright@yale.edu
Study contacts (from the official record)
- Nicole Wright, BS · 203-785-3488 · n.wright@yale.edu
- Adam Naples, PhD · 203-785-2583 · adam.naples@yale.edu
Similar studies in Connecticut
All healthy volunteers studies in Connecticut →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
Pfizer
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersEarly Phase 1Overnight stay mentioned
Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder
Yale University
- Location
- New Haven, CT
- Eligibility basics
- Ages 21–70
- RecruitingHealthy volunteersPhase 1
MK-0947 PN-002: An Open-label Study to Evaluate Brain α-synuclein Deposition Using Positron Emission Tomography (PET) and [¹⁸F]MK-0947 in Participants With Parkinson's Disease (PD)
XingImaging, LLC
- Location
- New Haven, CT
- Eligibility basics
- Ages 40–80
- RecruitingHealthy volunteersEarly Phase 1
A Study of the Pharmacokinetics, Biodistribution and Dosimetry of Granzyme-B Targeted [Cu-64]-Labeled PET Radiotracers in Adult Healthy Volunteers
Ratio Therapeutics, Inc.
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–60